(Q41180408)

27 September 2017

1 reference

MDMA

0 references

title

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). (English)

1 reference

27 September 2017

U D McCann

1 reference

27 September 2017

S O Slate

series ordinal

1 reference

27 September 2017

G A Ricaurte

series ordinal

1 reference

27 September 2017

publication date

1 August 1996

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

107-115

1 reference

Ecstasy induced hepatitis mimicking viral hepatitis

27 September 2017

cites work

1 reference

12 December 2020

Survival following intentional massive overdose of 'Ecstasy'.

1 reference

12 December 2020

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain

1 reference

12 December 2020

Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.

1 reference

12 December 2020

Psychiatric complications of 'Ecstasy' use

1 reference

12 December 2020

Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

MDMA (Ecstasy) precipitation of panic disorder

1 reference

12 December 2020

"Ecstasy" and sudden cardiac death

1 reference

12 December 2020

Cerebral venous sinus thrombosis induced by 'ecstasy'.

1 reference

12 December 2020

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

12 December 2020

Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

1 reference

12 December 2020

1 reference

12 December 2020

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

12 December 2020

Ecstasy overdose: a case study

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys

1 reference

12 December 2020

Information on "Ecstasy"

1 reference

12 December 2020

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

1 reference

12 December 2020

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

12 December 2020

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

12 December 2020

"Ecstasy" (MDMA)-induced panic

1 reference

12 December 2020

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

12 December 2020

Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine)

1 reference

12 December 2020

Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations

1 reference

12 December 2020

Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion

1 reference

12 December 2020

1 reference

12 December 2020

Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

12 December 2020

Ecstasy and Whizz at a rave resulting in a major burn plus complications

1 reference

12 December 2020

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

1 reference

12 December 2020

Treating MDMA ('Ecstasy') toxicity

1 reference

12 December 2020

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine

1 reference

12 December 2020

MDMA ("ecstasy") and panic disorder: induction by a single dose

1 reference

12 December 2020

Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep

1 reference

12 December 2020

Intracranial haemorrhage associated with ingestion of 'ecstasy'.

1 reference

12 December 2020

‘Ecstasy’ Psychosis and Flashbacks

1 reference

12 December 2020

Cerebral infarction in association with Ecstasy abuse

1 reference

12 December 2020

Subjective reports of the effects of MDMA in a clinical setting

1 reference

12 December 2020

'Ecstasy' induced pneumomediastinum

1 reference

12 December 2020

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

1 reference

12 December 2020

A case of MAO inhibitor/MDMA interaction: agony after ecstasy

1 reference

12 December 2020

["Ecstasy"-induced psychotic depersonalization syndrome]

1 reference

12 December 2020

MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series

1 reference

12 December 2020

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

12 December 2020

Chronic atypical psychosis associated with MDMA ("ecstasy") abuse

1 reference

12 December 2020

'Ecstasy' and intracerebral haemorrhage

1 reference

12 December 2020

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

12 December 2020

Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

1 reference

12 December 2020

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

1 reference

12 December 2020

'Ecstasy' ingestion: a case report of severe complications

1 reference

12 December 2020

Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

1 reference

12 December 2020

Another death from Ecstacy

1 reference

12 December 2020

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

1 reference

12 December 2020

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

12 December 2020

Death after ecstasy ingestion: neuropathological findings

1 reference

12 December 2020

Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users

1 reference

12 December 2020

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

1 reference

12 December 2020

Urinary retention with misuse of "ecstasy"

1 reference

12 December 2020

M.D.M.A. ("Ecstasy"); a case of possible drug-induced psychosis

1 reference

12 December 2020

Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing

1 reference

12 December 2020

Hyponatraemia and catatonic stupor after taking "ecstasy".

1 reference

12 December 2020

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

1 reference

12 December 2020

Ecstasy-fueled 'rave' parties become dances of death for English youths

1 reference

12 December 2020

Delayed severe rhabdomyolysis after taking 'ecstasy'.

1 reference

12 December 2020

Ecstasy--dental implications

1 reference

12 December 2020

A hyperthermic reaction to 'ecstasy'.

1 reference

12 December 2020

Psychiatric illness associated with "ecstasy".

1 reference

12 December 2020

"Ecstasy" and liver transplantation

1 reference

12 December 2020

Ecstasy and the dance of death

1 reference

12 December 2020

Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites

1 reference

12 December 2020

XTC-induced hepatitis

1 reference

12 December 2020

Methylenedioxyamphetamine ('Ecstasy') associated keratopathy

1 reference

12 December 2020

Cerebral Infarction Associated with 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) Abuse

1 reference

12 December 2020

Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations

1 reference

12 December 2020

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

12 December 2020

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

12 December 2020

Subarachnoid haemorrhage associated with MDMA abuse

1 reference

12 December 2020

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00002018-199615020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1046750561

0 references

1 reference